PL-8177

PL-8177 is a synthetic selective melanocortin MC1 receptor agonist. It is being developed for the treatment of inflammatory bowel disease due to its anti-inflammatory properties.

In the literature, PL-8177 appears most often in work focused on inflammation, gut health and immune support. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.

PL-8177 is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.